KKR (KKR) is finalizing terms to acquire EQT AB-backed Karo Healthcare in a transaction that could value the Sweden-based consumer health firm at more than 2.5 billion euros ($2.7 billion), Bloomberg reported Tuesday, citing people familiar with the matter.
Talks are in the final stages but could still be postponed or called off, according to the report, citing the people.
KKR and EQT didn't immediately respond to requests for comment from MT Newswires.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.